Personal letters between Princess Diana and actor Terence Stamp that reveal the depth of their intimate friendship are going ...

"I came into this job and the chemistry reads with more than enough information and knowledge and understanding of what this role required," she said ...

A federal appeals court granted Express Scripts Inc. ‘s petition for a jury trial in a case from 120 cities, towns, and counties across West Virginia alleging the company played a central role in the ...

“The Seventh Amendment entitles litigants to a jury trial unless the claim would have been heard, and the remedy awarded, by courts of equity at the Founding," Judge Julius Richardson wrote for the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The dispute centers on ...

Charter has taken Express Scripts to court, accusing the pharmacy-benefit manager of holding back millions in drug rebate payments tied to prescription claims from 2020 through 2022. The complaint, ...

The Federal Trade Commission’s Feb.4 consent order with Express Scripts represents the most consequential structural overhaul of the pharmacy benefit manager industry to date. Policymakers and ...

Express Scripts agreed to pay a $1.5 million administrative penalty and implement corrective actions following an investigation by the West Virginia Offices of the Insurance Commissioner. Between May ...

For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

FTC allegations centered on “Big 3” PBMs using anticompetitive rebating and affiliated-pharmacy channel dynamics to inflate insulin list prices and capture rebate and margin-driven revenues.